4.5 Article

The adaptor protein FHL2 enhances the cellular innate immune response to influenza A virus infection

Journal

CELLULAR MICROBIOLOGY
Volume 14, Issue 7, Pages 1135-1147

Publisher

WILEY-BLACKWELL
DOI: 10.1111/j.1462-5822.2012.01787.x

Keywords

-

Funding

  1. IZKF Muenster [Wix2/005/10]
  2. Deutsche Forschungsgemeinschaft (DFG) [EH 235 1/1, LU 477 13/1, SFB492A17]
  3. FluRearchNet, a nationwide network on zoonotic influenza
  4. German ministry of Education and Research (BMBF)

Ask authors/readers for more resources

The innate immune response of influenza A virus-infected cells is predominantly mediated by type I interferon-induced proteins. Expression of the interferon beta (IFN beta) itself is initiated by accumulating viral RNA and is transmitted by different signalling cascades that feed into activation of the three transcriptional elements located in the IFN beta promoter, AP-1, IRF-3 and NF-?B. FHL2 (four-and-a-half LIM domain protein 2) is an adaptor molecule that shuttles between membrane and nucleus regulating signalling cascades and gene transcription. Here we describe FHL2 as a novel regulator of influenza A virus propagation. Using mouse FHL2 wild-type, knockout and rescued cells and human epithelial cells with different expression levels of FHL2 we showed that FHL2 decreases influenza A virus propagation by regulating the intrinsic cellular antiviral immune response. On virus infection FHL2 translocates into the nucleus, potentiating the IRF-3-dependent transcription of the IFN beta gene.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Virology

Phosphorylation of Influenza A Virus NS1 at Serine 205 Mediates Its Viral Polymerase-Enhancing Function

Amol Patil, Darisuren Anhlan, Veronica Ferrando, Angeles Mecate-Zambrano, Alexander Mellmann, Viktor Wixler, Yvonne Boergeling, Stephan Ludwig

Summary: The phosphorylation of NS1 S205 in H1N1 virus is regulated by the cellular kinase CK2 and plays a significant role in viral replication in hosts. Phosphorylated NS1 S205 enhances viral polymerase activity by interacting efficiently with the host restriction factor DDX21, suggesting a potential target for antiviral intervention.

JOURNAL OF VIROLOGY (2021)

Article Public, Environmental & Occupational Health

Decontamination of disposable respirators for reuse in a pandemic employing in-situ-generated peracetic acid

Christian Boeing, Christian Sandten, Eike R. Hrincius, Darisuren Anhlan, Andreas Dworog, Stephanie Hanning, Thilo Kuennemann, Christopher Niehues, Thomas Schupp, Edyta Stec, Julius Thume, Daniel Triphaus, Markus Wilkens, Holger Uphoff, Josef Zuendorf, Anja Jacobshagen, Martin Kreyenschmidt, Stephan Ludwig, Hans-Christoph Mertins, Alexander Mellmann

Summary: This study aimed to develop a simple, inexpensive, and ecological method for decontamination of disposable FFPs while preserving filtration efficiency and material integrity. The results showed that immersion in a 6% acetic acid and 6% hydrogen peroxide solution for 30 minutes completely eliminated contaminants without compromising the performance of FFPs.

AMERICAN JOURNAL OF INFECTION CONTROL (2022)

Article Biotechnology & Applied Microbiology

Small spleen peptides prevent development of psoriatic arthritis via restoration of peripheral tolerance

Viktor Wixler, Igor Z. Zaytsev, Rafael Leite Dantas, Tanja Schied, Yvonne Boergeling, Veronika Luehrmann, Georg Varga, Doerthe Masemann, Stephan Ludwig

Summary: The restoration of immune tolerance is crucial in treating autoimmune diseases. Small splenic peptides (SSPs) have been found to convert dendritic cells (DCs) into tolerogenic cells, leading to the differentiation of naive CD4+ cells into Foxp3-expressing T regulatory cells (Tregs), and effectively suppressing the development of psoriatic arthritis.

MOLECULAR THERAPY (2022)

Article Biochemistry & Molecular Biology

Inhibition of Phosphatidylinositol 3-Kinase by Pictilisib Blocks Influenza Virus Propagation in Cells and in Lungs of Infected Mice

Stefanie Deinhardt-Emmer, Laura Jaeckel, Clio Haering, Sarah Boettcher, Janine J. Wilden, Brigitte Glueck, Regine Heller, Michaela Schmidtke, Mirijam Koch, Bettina Loeffler, Stephan Ludwig, Christina Ehrhardt

Summary: The PI3K inhibitor Pictilisib has been identified as a potent inhibitor of IV propagation, showing reduced viral titers and inflammatory response in the lungs, making it a promising candidate for anti-IV therapies. Repurposing previously approved substances is a cost-effective and efficient way for the development of novel antiviral strategies.

BIOMOLECULES (2021)

Article Immunology

MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination

Yeonsu Kim, Xiaoyan Zheng, Kathrin Eschke, M. Zeeshan Chaudhry, Federico Bertoglio, Adriana Tomic, Astrid Krmpotic, Markus Hoffmann, Yotam Bar-On, Julia Boehme, Dunja Bruder, Thomas Ebensen, Linda Brunotte, Stephan Ludwig, Martin Messerle, Carlos Guzman, Ofer Mandelboim, Michael Hust, Stefan Poehlmann, Stipan Jonjic, Luka Cicin-Sain

Summary: CMV vectors induce long-term cellular immunity and long-term immune protection against clinically relevant respiratory pathogens.

CELLULAR & MOLECULAR IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses

Andre Schreiber, Dorothee Viemann, Jennifer Schoening, Sebastian Schloer, Angeles Mecate Zambrano, Linda Brunotte, Aileen Faist, Michael Schoefbaenker, Eike Hrincius, Helen Hoffmann, Markus Hoffmann, Stefan Poehlmann, Ursula Rescher, Oliver Planz, Stephan Ludwig

Summary: The Raf/MEK/ERK signaling pathway may represent a target for therapeutic intervention against SARS-CoV-2 infections, and ATR-002 shows promising potential as a candidate drug with strong antiviral activity and the ability to prevent COVID-19-associated inflammation.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Article Virology

Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases

M. Zeeshan Chaudhry, Kathrin Eschke, Markus Hoffmann, Martina Grashoff, Leila Abassi, Yeonsu Kim, Linda Brunotte, Stephan Ludwig, Andrea Kroeger, Frank Klawonn, Stefan H. Poehlmann, Luka Cicin-Sain

Summary: The emergence of new SARS-CoV-2 variants with spike mutations highlights the potential for adaptation and evolution of the coronavirus, despite the stable consensus genotype of clinical isolates.

JOURNAL OF VIROLOGY (2022)

Article Multidisciplinary Sciences

Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection

Jonas Schuhenn, Toni Luise Meister, Daniel Todt, Thilo Bracht, Karin Schork, Jean-Noel Billaud, Carina Elsner, Natalie Heinen, Zehra Karakoese, Sibylle Haid, Sriram Kumar, Linda Brunotte, Martin Eisenacher, Yunyun Di, Jocelyne Lew, Darryl Falzarano, Jieliang Chen, Zhenghong Yuan, Thomas Pietschmann, Bettina Wiegmann, Hendrik Uebner, Christian Taube, Vu Thuy Khanh Le-Trilling, Mirko Trilling, Adalbert Krawczyk, Stephan Ludwig, Barbara Sitek, Eike Steinmann, Ulf Dittmer, Kerry J. Lavender, Kathrin Sutter, Stephanie Pfaender

Summary: This study found that different subtypes of IFN-alpha have varying antiviral activity against SARS-CoV-2, with IFN-alpha 5 showing the highest efficacy. Combination treatment with the broad antiviral drug remdesivir enhanced the antiviral effect. These findings are important for understanding the mechanism of IFN-I-mediated antiviral response and developing treatments for COVID-19.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Cell & Tissue Engineering

SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids

Yotam Menuchin-Lasowski, Andre Schreiber, Aaron Lecanda, Angeles Mecate-Zambrano, Linda Brunotte, Olympia E. Psathaki, Stephan Ludwig, Thomas Rauen, Hans R. Schoeler

Summary: Several studies have shown that SARS-CoV-2 can infect and replicate in retinal cells, inducing inflammatory responses and relying on ACE2 for infection. Therefore, it is important to monitor the potential effects of COVID-19 on the retina.

STEM CELL REPORTS (2022)

Article Respiratory System

Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages

Katja Hoenzke, Benedikt Obermayer, Christin Mache, Diana Fathykova, Mirjana Kessler, Simon Doekel, Emanuel Wyler, Morris Baumgardt, Anna Loewa, Karen Hoffmann, Patrick Graff, Jessica Schulze, Maren Mieth, Katharina Hellwig, Zeynep Demir, Barbara Biere, Linda Brunotte, Angeles Mecate-Zambrano, Judith Bushe, Melanie Dohmen, Christian Hinze, Sefer Elezkurtaj, Mario Toennies, Torsten T. Bauer, Stephan Eggeling, Hong-Linh Tran, Paul Schneider, Jens Neudecker, Jens C. Rueckert, Kai M. Schmidt-Ott, Jonas Busch, Frederick Klauschen, David Horst, Helena Radbruch, Josefine Radke, Frank Heppner, Victor M. Corman, Daniela Niemeyer, Marcel A. Mueller, Christine Goffinet, Ronja Mothes, Anna Pascual-Reguant, Anja Erika Hauser, Dieter Beule, Markus Landthaler, Stephan Ludwig, Norbert Suttorp, Martin Witzenrath, Achim D. Gruber, Christian Drosten, Leif-Erik Sander, Thorsten Wolff, Stefan Hippenstiel, Andreas C. Hocke

Summary: This study reveals that severe lung injury in COVID-19 may result from macrophage-triggered immune activation rather than direct viral damage to the alveolar compartment.

EUROPEAN RESPIRATORY JOURNAL (2022)

Review Cell Biology

Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond

Aileen Faist, Josua Janowski, Sriram Kumar, Saskia Hinse, Duygu Merve Caliskan, Julius Lange, Stephan Ludwig, Linda Brunotte

Summary: Respiratory infections with newly emerging zoonotic viruses can cause severe disease and high mortality by perturbing the human immune responses. This review discusses the similarities and differences between SARS-CoV-2 and highly pathogenic avian influenza viruses in terms of immune induction, disease dynamics, and long-term sequelae. It also highlights important lessons about the effectiveness of antiviral and immunomodulatory therapeutic strategies learned from this pandemic.

CELLS (2022)

Article Immunology

3D Ex vivo tissue platforms to investigate the early phases of influenza a virus- and SARS-CoV-2-induced respiratory diseases

Sebastian Schloer, Daniel Treuherz, Aileen Faist, Marlous de Witt, Katharina Wunderlich, Rainer Wiewrodt, Karsten Wiebe, Peter Barth, Joo-Hee Waelzlein, Susann Kummer, Anne Balkema-Buschmann, Stephan Ludwig, Linda Brunotte, Ursula Rescher

Summary: In order to study the viral life cycle, describe the pathophysiological consequences of viral infection, and explore possible drug targets and treatment options, it is necessary to establish physiologically relevant models. This study established a murine lung tissue explant platform for studying influenza A virus and SARS-CoV-2. The platform demonstrated efficient viral replication, release of inflammatory cytokines, and induction of antiviral interferon response.

EMERGING MICROBES & INFECTIONS (2022)

Article Pharmacology & Pharmacy

The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs

Andre Schreiber, Benjamin Ambrosy, Oliver Planz, Sebastian Schloer, Ursula Rescher, Stephan Ludwig

Summary: In this study, researchers found that the MEK1/2 inhibitor ATR-002 can synergistically enhance the effect of direct-acting antivirals against SARS-CoV-2, reducing the effective concentrations of the drugs and minimizing side effects.

PHARMACEUTICS (2022)

Article Virology

MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases

Stephan Ludwig, Stephan Pleschka, Oliver Planz

Summary: Acute hyperinflammatory virus infections, such as influenza or coronavirus disease-19, are still a major health burden worldwide. Direct-acting antivirals may induce viral resistance, while a host-targeted strategy using inhibitors of the cellular Raf/MEK/ERK kinase cascade shows potential in blocking virus replication and suppressing cytokine response. The MEK inhibitor Zapnometinib has shown evidence of clinical benefit in a phase-II clinical trial.

CURRENT OPINION IN VIROLOGY (2023)

Article Cell Biology

Pathophysiological Mechanisms of Cardiac Dysfunction in Transgenic Mice with Viral Myocarditis

Matthias Rohrbeck, Verena Hoerr, Ilaria Piccini, Boris Greber, Jan Sebastian Schulte, Sara-Sophie Huebner, Elena Jeworutzki, Carsten Theiss, Veronika Matschke, Joerg Stypmann, Andreas Unger, Huyen Tran Ho, Paul Disse, Nathalie Strutz-Seebohm, Cornelius Faber, Frank Ulrich Mueller, Stephan Ludwig, Ursula Rescher, Wolfgang A. A. Linke, Karin Klingel, Karin Busch, Stefan Peischard, Guiscard Seebohm

Summary: Using a transgenic mouse strain (TG) containing a CVB3 Delta VP0 genome, we have revealed virus-mediated cardiac pathophysiological processes in vivo and in vitro. Transgenic mice showed significant alterations in cardiac function, pathologic ECG alterations, calcium homeostasis, intracellular organization, and gene expression. The results also suggest that mitochondrial impairment may contribute to cardiac contractile dysfunction.

CELLS (2023)

No Data Available